Morepen Laboratories Shares Surge 18% On Launch Of 4 Products

Shares of Morepen Laboratories climbed 18 per cent successful Thursday's waste and acquisition aft nan API shaper launched 4 caller products namely Ticapen, UdoFix, LycoMore, Acifix successful nan ongoing period to cater nan home market. This is summation to nan motorboat of Empamore successful March.

Following nan development, nan banal roseate 17.94 per cent to deed a precocious of Rs 64.20, slashing its year-to-date losses to 21.45 per cent.

Ticapen (Ticagrelor 60mg/90mg) is simply a clinically proven, affordable antiplatelet therapy for ACS, Angina, and MI. UdoFix is simply a benchmark successful hepatoprotective therapy, it said. LycoMore Syrup blends Lycopene, basal vitamins, and minerals to support immunity and recovery. Acifix Raft Suspension offers targeted alleviation for GERD, reflux, and heartburn, Morepen Laboratories said.

With nan existent formulation business size of astir Rs 325 crore, Morepen Laboratories is accelerating toward nan Rs 1,000-crore target complete nan adjacent 5 years, Morepen Laboratories said.

This would beryllium driven by deeper marketplace penetration, an expanded section force, and a increasing portfolio of cost-efficient, globally compliant therapies, nan API supplier shaper informed banal exchanges. 

"With these additions and a attraction connected in-house R&D, API strength, and objective partnerships, Morepen continues to lead pinch purpose—making medicines that matter, and making healthcare much accessible, affordable, and effective for millions of lives," nan API shaper said,

Morepen Laboratories is India’s largest exporter of APIs for six globally utilized molecules specified arsenic Loratadine, Montelukast, Desloratadine, Atorvastatin, Rosuvastatin, and Fexofenadine. It  has a beingness successful 82 countries. It has an yearly API manufacturing capacity of 144 metric tons. 

In nan BSE filing, nan institution said it was "continuing its committedness to connection innovative latest products marking an different milestone reinforcing nan expert and diligent trust. These caller launches bespeak our unwavering attraction connected research-led innovation, objective excellence, and affordable healthcare access, addressing captious needs successful cardiology, hepatology, nutrition, and diabetology."

Published on: Apr 24, 2025 3:17 PM IST